logo

For the Inventor, By the Inventor

Wildwood, MO, United States of America

Wei Huang

This inventor holds 21 USPTO granted patents and 2 published patent applications and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Gpi Nil Holdings Inc., Pharmacia Corporation, Pfizer Corporation. Active years: 1999-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Huang. Retrieved from https://idiyas.com/inventor/wei-huang-vltbstja

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 

% Patents Active = 52.4

 

Average Co-Inventor Count = 5.2

ph-index = 6

Forward Citations = 120(Granted Patents)


Location History:

  • Chesterfield, MO (US) (1999 - 2001)
  • Baltimore, MD (US) (1999 - 2001)
  • Wildwood, MD (US) (2002)
  • Wildwood, MO (US) (2003 - 2015)

Company Filing History:

goldMedal8 out of 67 
 
Gpi Nil Holdings Inc.
 patents
silverMedal6 out of 220 
 
Pharmacia Corporation
 patents
bronzeMedal5 out of 4,488 
 
Pfizer Corporation
 patents
4. 1 out of 7 
 
Gliamed, Inc.
 patents
5. 1 out of 2,538 
 
Warner-Lambert Company
 patents

Years Active: 1999-2015

Loading Chart...
Loading Chart...
Areas of Expertise:
Chemokine Receptor Agonists
Heterocyclic Compounds
Pharmaceutical Compositions
Coagulation Cascade
Aza Compounds
Nicotinamide Derivatives
Polycyclic Compounds
Selective Inhibition
Sulfonamides
Ureas
Carbamates
21 patents (USPTO):Explore Patents
1. 8946413 - 3-aminocyclopentanecarboxamides as chemokine receptor agonists (2015-02-03),
2. 8293903 - 3-aminocyclopentanecarboxamides as chemokine receptor agonists (2012-10-23),
3. 8067589 - Heterocyclic compounds useful in treating diseases and conditions (2011-11-29),
4. 7902373 - Nicotinamide derivatives (2011-03-08),
5. 7582643 - Heterocyclic compounds useful in treating diseases and conditions (2009-09-01),
6. 7253169 - Aza compounds, pharmaceutical compositions and methods of use (2007-08-07),
7. 7119094 - Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade (2006-10-10),
8. 7105559 - Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade (2006-09-12),
9. 6969715 - 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade (2005-11-29),
10. 6908919 - Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade (2005-06-21),
11. 6828338 - Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade (2004-12-07),
12. 6664255 - Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade (2003-12-16),
13. 6624180 - Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade (2003-09-23),
14. 6417189 - AZA compounds, pharmaceutical compositions and methods of use (2002-07-09),
15. 6294551 - N-linked sulfonamides of heterocyclic thioesters (2001-09-25),

Title: Wei Huang: Innovator in Pharmaceutical Chemistry

Introduction

Wei Huang, based in Wildwood, MO, is a prominent inventor in the field of pharmaceutical chemistry, boasting an impressive portfolio of 21 patents. His innovations primarily focus on chemical compounds with significant applications in medicine.

Latest Patents

Among his latest contributions to the field are notable patents related to 3-aminocyclopentanecarboxamides, which function as chemokine receptor agonists. These patents detail compounds represented by Formula I(a) or I(b), along with their pharmaceutically acceptable salts, defining various substituents integral to their chemical structure and function.

Career Highlights

Wei Huang has made substantial contributions during his tenure at reputable organizations such as GPI Nil Holdings Inc. and Pharmacia Corporation. Throughout his career, he has been dedicated to advancing the understanding and application of chemical compounds in pharmacology, significantly impacting therapeutic strategies.

Collaborations

During his professional journey, Wei has collaborated with several notable colleagues, including John Isidro Trujillo and Gregory S. Hamilton. Their combined expertise has fostered innovative approaches to pharmaceutical research and development.

Conclusion

In summary, Wei Huang's work exemplifies the intersection of innovation and practical application in the pharmaceutical industry. With a growing list of patents and a history of impactful collaborations, he continues to contribute to advancements in medicinal chemistry, paving the way for future discoveries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…